A5007040195- Lymphatic System and Diseases
- Reconstructive Surgery and Microvascular Techniques
- Mesenchymal stem cell research
- Breast Implant and Reconstruction
- Body Contouring and Surgery
- Electrospun Nanofibers in Biomedical Applications
- Tissue Engineering and Regenerative Medicine
- Wound Healing and Treatments
- Lymphatic Disorders and Treatments
- Nasal Surgery and Airway Studies
- Surgical site infection prevention
- Reconstructive Facial Surgery Techniques
- Diagnosis and Treatment of Venous Diseases
- Pressure Ulcer Prevention and Management
- Breast Cancer Treatment Studies
- Orthopedic Surgery and Rehabilitation
- Cutaneous Melanoma Detection and Management
- Prostate Cancer Diagnosis and Treatment
- Systemic Sclerosis and Related Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Peripheral Nerve Disorders
- Male Breast Health Studies
- Bone fractures and treatments
- Obstructive Sleep Apnea Research
- Cancer survivorship and care
Zealand University Hospital
2021-2024
Rigshospitalet
2012-2024
Roskilde Sygehus
2018-2024
Odense University Hospital
2014-2023
University of Southern Denmark
2016-2022
Region of Southern Denmark
2022
University of Copenhagen
2012-2022
Roskilde University
2022
Copenhagen University Hospital
2022
Odense Municipality
2022
Abstract The impact of breast cancer-related lymphedema (BCRL) on long-term quality life is unknown. aim this study was to investigate the BCRL health-related (HRQoL) up 10 years after cancer treatment. This regional population-based enrolled patients treated for with axillary lymph node dissection between January 1st 2007 and December 31th 2017. Follow assessments included were conducted 2019 May 2020. outcome HRQoL, evaluated Lymphedema Functioning, Disability Health Questionnaire,...
Breast cancer-related lymphedema (BCRL) is a debilitating late complication with lack of treatment opportunities. Recent studies have suggested that mesenchymal stromal cells can alleviate lymphedema. Herein, we report the results from first human pilot study freshly isolated adipose-derived regenerative (ADRC) for treating 6 months follow-up. Ten BCRL patients were included. ADRC was injected directly into axillary region, which combined scar-releasing fat graft procedure. Primary endpoints...
Background: Postmastectomy pain syndrome is a common and disabling side effect of breast cancer treatment. Medical treatment seems to be insufficient for considerable proportion patients. Fat grafting has shown promise in relieving from postmastectomy syndrome, but no randomized clinical trial comparing fat sham operation been performed date. The authors’ objective was compare the compared treating syndrome. Methods: authors conducted single-center, double-blind, with two arms between...
Oral and extremity defect reconstruction can often require a flap that is thin, traditionally, the radial forearm free has been used, however, this significant donor site morbidity. Over last decade, medial sural artery perforator (MSAP) emerged as possible alternative with lower We present our experiences review literature regarding promising but challenging flap.The study was retrospective case series in university hospital setting. All patients who had MSAP performed at institution were...
Indocyanine green lymphangiography (ICG-L) allows real-time investigation of lymphatics. Plastic surgeons performing lymphatic reconstruction use the ICG-L for patient selection and stratification using MD Anderson (MDA) Arm Dermal Backflow (ADB) grading systems. However, applicability in evaluating breast cancer-related lymphedema (BCRL) is sparse not well established. This study comprehensively examines usability assessment BCRL. We prospectively performed 237 BCRL patients between January...
Abstract Lymphedema is one of the most frequent side effects following cancer treatment, and treatment opportunities for it are currently lacking. Stem cell therapy has been proposed as a possible novel modality. This study was first case in which freshly isolated adipose-derived stromal cells were used to treat lymphedema. Treatment given cell-assisted lipotransfer 4.07 × 107 injected with 10 ml lipoaspirate axillary region. Four months after patient reported great improvement daily...
Breast cancer-related lymphedema (BCRL) is a debilitating sequela affecting up to 1 in 3 breast cancer survivors. Treatments are palliative and do not address the underlying lymphatic injury. Recent preclinical nonrandomized studies have shown promising results using adipose-derived regenerative cells (ADRCs) lipotransfer alleviating BCRL through regeneration of tissue. However, no randomized controlled trial has been performed an attempt eliminate placebo effect.
Abstract Patients with breast cancer-related lymphedema (BCRL) have reduced quality of life and arm function. Current treatments are palliative, improving lacking. Preclinical studies suggested that adipose-derived regenerative cells (ADRCs) can alleviate lymphedema. We, therefore, aimed to assess whether ADRCs in clinical reality long-term follow-up. We treated 10 patients BCRL using a scar-releasing lipotransfer the axillary region, all were followed 1, 3, 6, 12, 48 months after treatment....
Reduction mammoplasty effectively improves quality of life for women with macromastia. However, little is known whether surgical- or patient-related factors affect satisfaction.The authors sought to investigate associated altered patient satisfaction following reduction mammoplasty.A cross-section study was performed by sending the BREAST-Q module all patients who had undergone between January 2009 and December 2018 at 2 tertiary Danish hospitals. Demographics pre-, peri-, postoperative...
Not much is known about long-term satisfaction of septoplasty. The goal this study was to assess disease specific quality life outcomes as well at more than 10 years follow-up after septoplasty.The conducted a retrospective questionnaire (based on the NOSE scale) in which sent every patient and followed up by telephone interview tertiary otorhinolaryngologic clinic.238 out 369 patients who underwent septoplasty accepted participate 222 were eligible. We found significant reduction score from...